Exact Mass: 342.25184440000004

Exact Mass Matches: 342.25184440000004

Found 382 metabolites which its exact mass value is equals to given mass value 342.25184440000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Megestrol

(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

C22H30O3 (342.21948299999997)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AB - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D000970 - Antineoplastic Agents

   

6alpha-Methyl-11-oxoprogesterone

6alpha-Methylpregn-4-ene-3,11,20-trione

C22H30O3 (342.21948299999997)


   

2alpha-Methyl-11-oxoprogesterone

2alpha-Methylpregn-4-ene-3,11,20-trione; 2alpha-Methyl-11-oxoprogesterone

C22H30O3 (342.21948299999997)


   

NSC63298

6beta,17-Dihydroxy-3,5-cyclo-5alpha,17alpha-pregn-20-ene-21-carboxylic acid, gamma-lactone

C22H30O3 (342.21948299999997)


   

E-64d

3-[[[(1S)-3-methyl-1[[(3S-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2S-oxiranecarboxylic acid, ethyl ester

C17H30N2O5 (342.215461)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid

2-hydroxy-6-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]benzoic acid

C22H30O3 (342.21948299999997)


2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid is found in nuts. 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid is a minor constituent of cashew nut shel D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

Guggulsterone

(1R,2R,10S,11S,14E,15S)-14-(1-methoxyethylidene)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,13-dione

C22H30O3 (342.21948299999997)


Guggulsterone is an ingredient in many nutritional supplements. Guggulsterone is a plant sterol derived from the gum resin (guggulu) of the tree Commiphora mukul. This sterol can inhibit NF-κB activation and downregulate the expression of inflammatory gene products such as COX-2 and MMP-9, which are major players in the development of arthritis. Guggulsterone also can suppress osteoclastogenesis induced by RANKL (receptor activator of NF-κB ligand), a bone-resorbing cytokine. The anti-inflammatory activity of C. mukul (guggul) has been compared with that of NSAIDs, namely phenylbutazone and ibuprofen. Guggulsterone is used to treat obesity, diabetes, hyperlipidemia, atherosclerosis, and osteoarthritis, and has been recently shown to antagonize the farnesoid X receptor and decrease the expression of bile acid-activated genes. It modulates activation of NF-kappaB, which has been closely linked with inflammatory diseases affected by guggulsterone. (PMID: 17475558, 15322087) [HMDB] Guggulsterone is an ingredient in many nutritional supplements. Guggulsterone is a plant sterol derived from the gum resin (guggulu) of the tree Commiphora mukul. This sterol can inhibit NF-κB activation and downregulate the expression of inflammatory gene products such as COX-2 and MMP-9, which are major players in the development of arthritis. Guggulsterone also can suppress osteoclastogenesis induced by RANKL (receptor activator of NF-κB ligand), a bone-resorbing cytokine. The anti-inflammatory activity of C. mukul (guggul) has been compared with that of NSAIDs, namely phenylbutazone and ibuprofen. Guggulsterone is used to treat obesity, diabetes, hyperlipidemia, atherosclerosis, and osteoarthritis, and has been recently shown to antagonize the farnesoid X receptor and decrease the expression of bile acid-activated genes. It modulates activation of NF-kappaB, which has been closely linked with inflammatory diseases affected by guggulsterone. (PMID: 17475558, 15322087).

   

13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid

(11E)-13-hydroxy-9-methoxy-10-oxooctadec-11-enoic acid

C19H34O5 (342.24061140000003)


13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid is found in cereals and cereal products. 13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid is isolated from corn. Isolated from corn. 13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid is found in cereals and cereal products.

   

2,3-Dinor-TXB2

(3Z)-5-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]pent-3-enoic acid

C18H30O6 (342.204228)


Fatty Acyl-Eicosanoid - metabolite of thromboxane. Found to be excreted via urinary tract at a higher level in diabetic rats. A study demonstrates that thromboxane as well as prostacyclin biosynthesis is increased in 2 murine models of atherogenesis and is secondary to increased in vivo platelet activation. Assessment of their generation in these models may afford the basis for future studies on the functional role of these eicosanoids in the evolution and progression of atherosclerosisThromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Fatty Acyl-Eicosanoid - metabolite of thromboxane. Found to be excreted via urinary tract at a higher level in diabetic rats. A study demonstrates that thromboxane as well as prostacyclin biosynthesis is increased in 2 murine models of atherogenesis and is secondary to increased in vivo platelet activation. Assessment of their generation in these models may afford the basis for future studies on the functional role of these eicosanoids in the evolution and progression of atherosclerosis

   

(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid

(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid

C18H30O6 (342.204228)


(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid is found in fruits. (-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid is isolated from the seeds of Sambucus nigra (elderberry). Isolated from the seeds of Sambucus nigra (elderberry). (-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid is found in fruits.

   

2,3-Dinor-6-keto-prostaglandin F1 a

5-[(1R,2R,3S,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


2,3-dinor-6-keto-prostaglandin F1 alpha is a major urinary prostacyclin metabolite, and is significantly higher in 9 patients with severe atherosclerosis and evidence of platelet activation. Prostacyclin is a potent vasodilator and platelet inhibitor produced by vascular endothelium. Endogenous production of prostacyclin under physiologic conditions is extremely low, far below the capacity of vascular tissue to generate this substance in response to stimulation in vitro. This may reflect a low frequency or intensity of stimulation of prostacyclin production. PGI2 synthase (PGIS), a catalyst of PGI2 formation from prostaglandin H2, is widely distributed and predominantly found in vascular endothelial and smooth muscle cells. PGI2 plays an important cardioprotective role increasingly appreciated in recent years in light of adverse effects of COX-2 inhibitors in clinical trials. This cardioprotection is thought to be mediated, in part, by prostacyclin inhibition of platelet aggregation. Multiple lines of evidence suggest that prostacyclin additionally protects from cardiovascular disease by pleiotropic effects on vascular smooth muscle. PGI2 inhibits proliferation of cultured vascular SMCs by inhibiting cell cycle progression from G1 to S phase. (PMID: 6231483, 7000774, 6231483, 16303599, 16533160, 17073611, 17164138)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 2,3-dinor-6-keto-prostaglandin F1 alpha is a major urinary prostacyclin metabolite, and is significantly higher in 9 patients with severe atherosclerosis and evidence of platelet activation. Prostacyclin is a potent vasodilator and platelet inhibitor produced by vascular endothelium. Endogenous production of prostacyclin under physiologic conditions is extremely low, far below the capacity of vascular tissue to generate this substance in response to stimulation in vitro. This may reflect a low frequency or intensity of stimulation of prostacyclin production. PGI2 synthase (PGIS), a catalyst of PGI2 formation from prostaglandin H2, is widely distributed and predominantly found in vascular endothelial and smooth muscle cells. PGI2 plays an important cardioprotective role increasingly appreciated in recent years in light of adverse effects of COX-2 inhibitors in clinical trials. This cardioprotection is thought to be mediated, in part, by prostacyclin inhibition of platelet aggregation. Multiple lines of evidence suggest that prostacyclin additionally protects from cardiovascular disease by pleiotropic effects on vascular smooth muscle. PGI2 inhibits proliferation of cultured vascular SMCs by inhibiting cell cycle progression from G1 to S phase. (PMID: 6231483, 7000774, 6231483, 16303599, 16533160, 17073611, 17164138)

   

17-Hydroxymethylethisterone

(1S,2R,4S,10R,11S,15S)-14-ethynyl-14-hydroxy-4-(hydroxymethyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C22H30O3 (342.21948299999997)


17-Hydroxymethylethisterone is a metabolite of danazol. Danazol is a derivative of the synthetic steroid ethisterone, a modified testosterone. Also known as 17alpha-ethinyl testosterone. Before becoming available as a generic drug, Danazol was marketed as Danocrine in the United States. It was approved by the U.S. Food and Drug Administration (FDA) as the first drug to specifically treat endometriosis in the early 1970s. Although effective for endometriosis, its use is limited by its masculinizing side-effects. (Wikipedia)

   

Monic acid

(E)-4-[(1S,2S,3R)-2,3-dihydroxy-4-[[(2S,3S)-3-[(2S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]cyclohexyl]-3-methylbut-2-enoic acid

C18H30O6 (342.204228)


Monic acid is a metabolite of mupirocin. Mupirocin (Bactroban or Centany) is an antibiotic originally isolated from Pseudomonas fluorescens NCIMB 10586, developed by Beecham. Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. It is used topically and is effective against Gram-positive bacteria, including MRSA. Mupirocin is a mixture of several pseudomonic acids, with pseudomonic acid A (PA-A) constituting greater than 90\\% of the mixture. (Wikipedia) No systemic absorption of mupirocin or its major metabolite, monic acid, has been detected in short courses of topical administration to healthy volunteers or to patients with epidermolysis bullosa after prolonged courses of therapy with Bactroban ointment. (PMID: 2112164)

   

2,3-dinor-6-oxoprostaglandin F1alpha

5-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


2,3-dinor-6-oxoprostaglandin F1alpha is also known as 2,3-Dinor-6-keto-PGF1alpha or 2,3-DKPGF1alpha. 2,3-dinor-6-oxoprostaglandin F1alpha is considered to be practically insoluble (in water) and acidic. 2,3-dinor-6-oxoprostaglandin F1alpha can be synthesized from prostaglandin F1alpha. 2,3-dinor-6-oxoprostaglandin F1alpha can be synthesized into 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha. 2,3-dinor-6-oxoprostaglandin F1alpha is an eicosanoid lipid molecule

   

14-oxo-DoHE(1-)

14-oxo-(4Z,7Z,10Z,12E,16Z,19Z)-Docosahexaenoic acid

C22H30O3 (342.21948299999997)


14-oxo-DoHE(1-) is also known as 14-oxo-(4Z,7Z,10Z,12E,16Z,19Z)-Docosahexaenoate. 14-oxo-DoHE(1-) is considered to be practically insoluble (in water) and acidic

   

N-Myristoyl Asparagine

3-carbamoyl-2-tetradecanamidopropanoic acid

C18H34N2O4 (342.25184440000004)


N-myristoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Eicosanedioic acid

Octadecane-1,18-dicarboxylic acid

C20H38O4 (342.2769948)


   

Pregn-4-en-20-yn-3-one, 17-hydroxy-2-(hydroxymethyl)-, (2alpha,17alpha)-

17-ethynyl-17-hydroxy-2-(hydroxymethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

C22H30O3 (342.21948299999997)


   

2,3-Dinor-6,15-dioxo-13,14-dihydroprostaglandin F1alpha

5-[3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


   

(Z)-5-((2R,3S,4S,6R)-4,6-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)tetrahydro-2H-pyran-3-yl)pent-3-enoic acid

(Z)-5-((2R,3S,4S,6R)-4,6-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)tetrahydro-2H-pyran-3-yl)pent-3-enoic acid

C18H30O6 (342.204228)


   

2,3-Dinor-TXB1

5-[2,4-dihydroxy-6-(3-hydroxyoct-1-en-1-yl)cyclohexyl]pentanoic acid

C19H34O5 (342.24061140000003)


   

5-[(1S,2S,3S,5R)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid

5-[(1S,2S,3S,5R)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


   

2-Hydroxy-6-pentadeca-8,11,14-trienyl benzoic acid

2-hydroxy-6-(pentadeca-8,11,14-trien-1-yl)benzoic acid

C22H30O3 (342.21948299999997)


   

2-[4-(Carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-11-yl]acetic acid

2-[11-(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecan-4-yl]acetic acid

C16H30N4O4 (342.226694)


   

Aloxistatin

Ethyl 3-({4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylic acid

C17H30N2O5 (342.215461)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

Cardenolide

3-(10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-furan-5-one

C23H34O2 (342.2558664)


   

1,2-Ethanediol monoricinoleate

2-Hydroxyethyl 12-hydroxyoctadec-9-enoic acid

C20H38O4 (342.2769948)


   

Medica 16

beta,Beta-tetramethylhexadecane-alpha,omega-dioic acid

C20H38O4 (342.2769948)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle, and this reduction is accompanied by an increase in insulin sensitivity. MEDICA16 is a selective agonist for GPR40 as well as selective partial agonists for GPR120[1][2].

   

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

C21H33F3 (342.25342140000004)


   

Prostaglandin F-main urinary metabolite

5-[3,5-dihydroxy-2-(8-hydroxy-3-oxooctyl)cyclopentyl]pent-3-enoic acid

C18H30O6 (342.204228)


   

Retinyl propionate

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl propanoic acid

C23H34O2 (342.2558664)


   

4-(10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxolan-2-one

4-(10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxolan-2-one

C23H34O2 (342.2558664)


   

Trimegestone

(8S,13S,14S,17S)-17-[(2S)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

C22H30O3 (342.21948299999997)


   
   
   

N-Methyldihydroquinicinol

N-Methyldihydroquinicinol

C21H30N2O2 (342.230716)


   
   

Methyl botryoloate

(+)-Methyl botryoloate

C18H30O6 (342.204228)


   
   
   

siccanin

NSC 135048

C22H30O3 (342.21948299999997)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   
   

3-Farnesyl-p-hydroxybenzoic acid

3-Farnesyl-p-hydroxybenzoic acid

C22H30O3 (342.21948299999997)


   
   

Methyl docosahexaenoate; all cis-DHA methyl ester

Methyl docosahexaenoate; all cis-DHA methyl ester

C23H34O2 (342.2558664)


   

MEDICA 16

3,3,14,14-tetramethylhexadecanedioic acid

C20H38O4 (342.2769948)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle, and this reduction is accompanied by an increase in insulin sensitivity. MEDICA16 is a selective agonist for GPR40 as well as selective partial agonists for GPR120[1][2].

   

12-HYDROXY-13-(HYDROXYMETHYL)-3,5,7-TRIMETHYLTETRADECA-2,4-DIENEDIOIC ACID

12-HYDROXY-13-(HYDROXYMETHYL)-3,5,7-TRIMETHYLTETRADECA-2,4-DIENEDIOIC ACID

C18H30O6 (342.204228)


   
   

Ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate

Ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate

C17H30N2O5 (342.215461)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

8-ethyloctadecanedioic acid

8-ethyloctadecanedioic acid

C20H38O4 (342.2769948)


   

24-Nor-cholen-(4)-dion-(3.22)|24-nor-cholene-(4)-dione-(3.22)|24-norchol-4-ene-3,22-dione

24-Nor-cholen-(4)-dion-(3.22)|24-nor-cholene-(4)-dione-(3.22)|24-norchol-4-ene-3,22-dione

C23H34O2 (342.2558664)


   

(E, E)-form/2, 5-Dihydroxy-3-(3, 7, 11-trimethyl-2, 6, 10-dodecatrienyl)benzaldehyde|3-farnesyl-2,5-dihydroxybenzaldehyde

(E, E)-form/2, 5-Dihydroxy-3-(3, 7, 11-trimethyl-2, 6, 10-dodecatrienyl)benzaldehyde|3-farnesyl-2,5-dihydroxybenzaldehyde

C22H30O3 (342.21948299999997)


   
   

3-acetoxystearic acid

3-acetoxystearic acid

C20H38O4 (342.2769948)


   

10(Z),13(E),15(E)-heptadecatrienylhydroquinone

10(Z),13(E),15(E)-heptadecatrienylhydroquinone

C23H34O2 (342.2558664)


   
   
   

20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,16-trione|octanorcucurbitacin B

20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,16-trione|octanorcucurbitacin B

C22H30O3 (342.21948299999997)


   
   

(+)-19-methoxyavarone|4-methoxyavarone

(+)-19-methoxyavarone|4-methoxyavarone

C22H30O3 (342.21948299999997)


   

20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,17-trione|octanorcucurbitacin A

20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,17-trione|octanorcucurbitacin A

C22H30O3 (342.21948299999997)


   

(6Z,8E)-6,8-Tricosadiene-4,19-diynoic acid

(6Z,8E)-6,8-Tricosadiene-4,19-diynoic acid

C23H34O2 (342.2558664)


   

3-(8,11,14-Heptadecatrienyl)-1,2-benzenediol

3-(8,11,14-Heptadecatrienyl)-1,2-benzenediol

C23H34O2 (342.2558664)


   
   

10-acetoxy-9-hydroxyamphilecta-8,10,12,14-tetraene

10-acetoxy-9-hydroxyamphilecta-8,10,12,14-tetraene

C22H30O3 (342.21948299999997)


   
   

(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol

(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol

C22H30O3 (342.21948299999997)


   

Deacetylpyrifolidine

Deacetylpyrifolidine

C21H30N2O2 (342.230716)


   
   

Retinyl Propionate-[d3]

Retinyl Propionate-[d3]

C23H34O2 (342.2558664)


   
   

Me ester-11,12,13-Trihydroxy-9,15-octadecadienoic acid

Me ester-11,12,13-Trihydroxy-9,15-octadecadienoic acid

C19H34O5 (342.24061140000003)


   

2-(7-hydroxy-4,8-dimethyl-3E,8-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene A

2-(7-hydroxy-4,8-dimethyl-3E,8-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene A

C22H30O3 (342.21948299999997)


   

Siccanochromen-H|Siccanochromene H

Siccanochromen-H|Siccanochromene H

C22H30O3 (342.21948299999997)


   

5-methyl-2-[(2E,7Z)-3,7,11-trimethyl-2,7-dodecadien-9-onyl]benzo-1,4-quinone

5-methyl-2-[(2E,7Z)-3,7,11-trimethyl-2,7-dodecadien-9-onyl]benzo-1,4-quinone

C22H30O3 (342.21948299999997)


   

2-[1,3,5,7-Tetramethyl-8-ethylbicyclo[4.2.0]octa-2,4-diene-7-yl]-3,5-dimethyl-6-methoxy-4H-pyran-4-one

2-[1,3,5,7-Tetramethyl-8-ethylbicyclo[4.2.0]octa-2,4-diene-7-yl]-3,5-dimethyl-6-methoxy-4H-pyran-4-one

C22H30O3 (342.21948299999997)


   
   

5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6-dodecadien-9-onyl]benzo-1,4-quinone

5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6-dodecadien-9-onyl]benzo-1,4-quinone

C22H30O3 (342.21948299999997)


   

HEXADECANOIC ACID DER (FR. LAVANDULA) A

HEXADECANOIC ACID DER (FR. LAVANDULA) A

C20H38O4 (342.2769948)


   
   

4-methoxy-2-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol|farnesylol

4-methoxy-2-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol|farnesylol

C23H34O2 (342.2558664)


   

(+)-(5S,8S,9R,10S)-20-methoxypuupehenone

(+)-(5S,8S,9R,10S)-20-methoxypuupehenone

C22H30O3 (342.21948299999997)


   
   

Tributyl prop-1-ene-1,2,3-tricarboxylate

Tributyl prop-1-ene-1,2,3-tricarboxylate

C18H30O6 (342.204228)


   

Metachromin U

Metachromin U

C22H30O3 (342.21948299999997)


A natural product found in Thorecta reticulata.

   
   
   

Tricyclo[6.3.1.0(1,5)]dodecan-9-ol, 2-benzoyloxy-4,4,8-trimethyl-

Tricyclo[6.3.1.0(1,5)]dodecan-9-ol, 2-benzoyloxy-4,4,8-trimethyl-

C22H30O3 (342.21948299999997)


   

methyl (9S,10R,11E,13S,15E)-9,10,13-trihydroxyoctadec-11,15-dienoate

methyl (9S,10R,11E,13S,15E)-9,10,13-trihydroxyoctadec-11,15-dienoate

C19H34O5 (342.24061140000003)


   

1-methoxypregna-1,4-dien-3,16-dione

1-methoxypregna-1,4-dien-3,16-dione

C22H30O3 (342.21948299999997)


   

(4S,5S)-4-(5-carboxylundecyl)-1-oxo-tetrahydrofuran-4-carboxylic acid methyl ester|spiculisporic acid C

(4S,5S)-4-(5-carboxylundecyl)-1-oxo-tetrahydrofuran-4-carboxylic acid methyl ester|spiculisporic acid C

C18H30O6 (342.204228)


   

2-(1-carboxydodecyl)-5-oxooxolane-2-carboxylic acid

2-(1-carboxydodecyl)-5-oxooxolane-2-carboxylic acid

C18H30O6 (342.204228)


   

(10R)-3c-Acetoxy-10r.13c-dimethyl-17c-vinyl-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren|3-O-acetylpregna-5,20-dien-3beta-ol|3beta-acetoxy-pregnadiene-(5,20)|3beta-acetoxypregna-5,20-diene|Essigsaeure-(pregnadien-(5.20)-yl-(3beta)-ester)|pregna-5,20-dien-3beta-ol-3-acetate|pregna-5,20-dien-3beta-yl acetate

(10R)-3c-Acetoxy-10r.13c-dimethyl-17c-vinyl-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren|3-O-acetylpregna-5,20-dien-3beta-ol|3beta-acetoxy-pregnadiene-(5,20)|3beta-acetoxypregna-5,20-diene|Essigsaeure-(pregnadien-(5.20)-yl-(3beta)-ester)|pregna-5,20-dien-3beta-ol-3-acetate|pregna-5,20-dien-3beta-yl acetate

C23H34O2 (342.2558664)


   

2-(3-hydroxy-8-methyl-4-methyliden-7-nonaenyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene B

2-(3-hydroxy-8-methyl-4-methyliden-7-nonaenyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene B

C22H30O3 (342.21948299999997)


   
   
   

7-oxo-20,21,22,23,24,25,26,27-octanor-14,18-cycloapotirucalla-1-en-3,4-olide|simaroubin E

7-oxo-20,21,22,23,24,25,26,27-octanor-14,18-cycloapotirucalla-1-en-3,4-olide|simaroubin E

C22H30O3 (342.21948299999997)


   

2R-(9-hydroxy-4,8-dimethyl-3E,7E-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene D

2R-(9-hydroxy-4,8-dimethyl-3E,7E-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene D

C22H30O3 (342.21948299999997)


   

6-beta-p-hydroxybenzoyloxygermacra-1(10),4-diene

6-beta-p-hydroxybenzoyloxygermacra-1(10),4-diene

C22H30O3 (342.21948299999997)


   

Dimethyl octadecanedioate

Dimethyl octadecanedioate

C20H38O4 (342.2769948)


   
   

2(R),3(S),4(S)-3,18-methylene-2alpha-acetoxyspongia-13(16),14-diene

2(R),3(S),4(S)-3,18-methylene-2alpha-acetoxyspongia-13(16),14-diene

C22H30O3 (342.21948299999997)


   
   

12-Acetoxy-abieta-8,11,13-trien-7-on|12-acetoxy-abieta-8,11,13-trien-7-one|sugiol acetate|Sugiol-Acetat|Sugiolacetat

12-Acetoxy-abieta-8,11,13-trien-7-on|12-acetoxy-abieta-8,11,13-trien-7-one|sugiol acetate|Sugiol-Acetat|Sugiolacetat

C22H30O3 (342.21948299999997)


   

15-Formylamino-8-isocyano-11(20)-amphilectene

15-Formylamino-8-isocyano-11(20)-amphilectene

C22H34N2O (342.2670994)


   

Icosanedioic acid

Eicosanedioic acid

C20H38O4 (342.2769948)


An alpha,omega-dicarboxylic acid that is the 1,18-dicarboxy derivative of octadecane.

   

cyclohexamantane|[12.12.02,11.03,16.05,18.06,11.07,20.09,22.010,25.012,17.012,21.013,24]hexacosane|[12312]hexamantane

cyclohexamantane|[12.12.02,11.03,16.05,18.06,11.07,20.09,22.010,25.012,17.012,21.013,24]hexacosane|[12312]hexamantane

C26H30 (342.234738)


   
   

3-hydroxy-1,5-dioxacyclohenicosane-6,21-dione

3-hydroxy-1,5-dioxacyclohenicosane-6,21-dione

C19H34O5 (342.24061140000003)


   

Me ester-(9S,10E,12S,13S,15Z)-9,12,13-Trihydroxy-10,15-octadecadienoic acid

Me ester-(9S,10E,12S,13S,15Z)-9,12,13-Trihydroxy-10,15-octadecadienoic acid

C19H34O5 (342.24061140000003)


   

3-geranyl-4-hydroxy-5-(3,3-dimethylallyl)-benzoicacid|3-geranyl-4-hydroxy-5-(3,3-dimethylallyl)-benzoic acid|3-geranyl-4-hydroxy-5-(3-methyl-2-butenyl)benzoic acid|3-geranyl-4-hydroxy-5-(3?,3?-dimethylallyl)benzoic acid|5-geranyl-4-hydroxy-5-(3-methyl-2-butenyl)-benzoic acid|myrsinoic acid|myrsinoic acid A

3-geranyl-4-hydroxy-5-(3,3-dimethylallyl)-benzoicacid|3-geranyl-4-hydroxy-5-(3,3-dimethylallyl)-benzoic acid|3-geranyl-4-hydroxy-5-(3-methyl-2-butenyl)benzoic acid|3-geranyl-4-hydroxy-5-(3?,3?-dimethylallyl)benzoic acid|5-geranyl-4-hydroxy-5-(3-methyl-2-butenyl)-benzoic acid|myrsinoic acid|myrsinoic acid A

C22H30O3 (342.21948299999997)


   
   

2-(8-hydroxy-4,8-dimethyl-3E,6Z-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene C

2-(8-hydroxy-4,8-dimethyl-3E,6Z-nonadienyl)-5-hydroxy-2,7-dimethyl-2H-chromene|daurichromene C

C22H30O3 (342.21948299999997)


   

Grifolin monomethyl ether

Grifolin monomethyl ether

C23H34O2 (342.2558664)


   
   
   

5beta,19-epoxy-20,21,22,23,24,25,26,27-octanorcucurbit-6-ene-3,17-dione|octanorcucurbitacin C

5beta,19-epoxy-20,21,22,23,24,25,26,27-octanorcucurbit-6-ene-3,17-dione|octanorcucurbitacin C

C22H30O3 (342.21948299999997)


   

14-nor-plakortide Q

14-nor-plakortide Q

C20H38O4 (342.2769948)


   

3-Farnesyl-4-hydroxybenzoesaure

3-Farnesyl-4-hydroxybenzoesaure

C22H30O3 (342.21948299999997)


   

(8Z,11Z,14Z)-5-(heptadeca-8,11,14-trienyl)benzene-1,3-diol|5,6-Dihydro-(all-Z)-5-(5,8,11,14-Heptadecatetraenyl)-1,3-benzenediol|5-heptadecatri-8(Z),11(Z),14(Z)-enylresorcinol

(8Z,11Z,14Z)-5-(heptadeca-8,11,14-trienyl)benzene-1,3-diol|5,6-Dihydro-(all-Z)-5-(5,8,11,14-Heptadecatetraenyl)-1,3-benzenediol|5-heptadecatri-8(Z),11(Z),14(Z)-enylresorcinol

C23H34O2 (342.2558664)


   
   

14,20-dihydroxycos-6(Z)-enoic acid

14,20-dihydroxycos-6(Z)-enoic acid

C20H38O4 (342.2769948)


   
   
   
   
   
   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid

NCGC00169827-03!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid

C18H30O6 (342.204228)


   

C22H30O3_2-Hydroxy-6-[(8Z,11Z)-8,11,14-pentadecatrien-1-yl]benzoic acid

NCGC00169660-02_C22H30O3_2-Hydroxy-6-[(8Z,11Z)-8,11,14-pentadecatrien-1-yl]benzoic acid

C22H30O3 (342.21948299999997)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid

C18H30O6 (342.204228)


   

2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzoic acid

2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzoic acid

C22H30O3 (342.21948299999997)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid [IIN-based on: CCMSLIB00000847643]

NCGC00169827-03!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid [IIN-based on: CCMSLIB00000847643]

C18H30O6 (342.204228)


   

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid [IIN-based: Match]

NCGC00169827-03!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid [IIN-based: Match]

C18H30O6 (342.204228)


   
   
   
   
   
   
   

Eicosanedioic acid

Eicosanedioic acid

C20H38O4 (342.2769948)


   

2,3-dinor, 6-keto-PGF1&alpha

6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid

C18H30O6 (342.204228)


   

Alcohol

1,9S,11R,15S-tetrahydroxy-13E-prostaene

C20H38O4 (342.2769948)


   

2,3-Dinor-TXB2

(Z)-5-[(2R,3S,4S)-4,6-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]oxan-3-yl]pent-3-enoic acid

C18H30O6 (342.204228)


   

16,17-epoxy-DHA

16,17-epoxy-docosa-4Z,7Z,10Z,12E,14E,19Z-hexaenoic acid

C22H30O3 (342.21948299999997)


   

Cannabidiol dimethyl ether

Cannabidiol dimethyl ether

C23H34O2 (342.2558664)


   

Docosahexaenoic Acid methyl ester

4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid, methyl ester

C23H34O2 (342.2558664)


   

2,3-Dinor-TXB1

9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid

C19H34O5 (342.24061140000003)


   

2,3-Dinor-11b-PGF2a

9S,11S,13S-Trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid

C18H30O6 (342.204228)


   

guggulsterone

(8XI,9xi,14xi,17E)-20-methoxypregna-4,17-diene-3,16-dione

C22H30O3 (342.21948299999997)


   

4Z,7Z,10Z,13Z,15E,19Z-17-keto-docosapentaenoic acid

17-keto-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid

C22H30O3 (342.21948299999997)


   

TrHA

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

methyl 9,12-dihydroxy-13-oxo-10-octadecenoate

methyl 9,12-dihydroxy-13-oxo-10-octadecenoate

C19H34O5 (342.24061140000003)


   

methyl 10,13-dihydroxy-9-oxo-11-octadecenoate

methyl 10,13-dihydroxy-9-oxo-11-octadecenoate

C19H34O5 (342.24061140000003)


   

16,17S-DHA-epoxide

16,17S-epoxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid

C22H30O3 (342.21948299999997)


   

2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid

2-hydroxy-6-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]benzoic acid

C22H30O3 (342.21948299999997)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

11-hydroxy-9,15,16-trioxooctadecanoic acid

(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid

C18H30O6 (342.204228)


   

13-hmo-18C acid

(11E)-13-hydroxy-9-methoxy-10-oxooctadec-11-enoic acid

C19H34O5 (342.24061140000003)


   

FA 23:6

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

FA 19:2;O3

9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid

C19H34O5 (342.24061140000003)


   

FA 20:1;O2

3-Acetoxy-octadecanoic acid

C20H38O4 (342.2769948)


   

Omphalotol B

methyl 11S,12R-dihydroxy-8-oxo-9E-octadecenoate

C19H34O5 (342.24061140000003)


   

FA 18:3;O4

9S,11,15S-trihydroxy-2,3-dinor-thromboxa-5Z,13E-dien-1-oic acid

C18H30O6 (342.204228)


   

PGF1a alcohol

1,9S,11R,15S-tetrahydroxy-13E-prostaene

C20H38O4 (342.2769948)


   

FA 22:7;O

13S,14S-epoxy-4Z,7Z,9E,11E,16Z,19Z- docosahexaenoic acid

C22H30O3 (342.21948299999997)


   

Siegesbeckin G

3R-(2E-dodecenoyloxy)-2R-hydroxy-4-methylpentanoic acid methyl ester

C19H34O5 (342.24061140000003)


   

FAHFA 20:0;O

3-octanoyloxy-dodecanoic acid

C20H38O4 (342.2769948)


   

Bixasteroid

8R,9S,10R,13S,14S-pregna-3S-methoxy-5,17(20)-diene-7,16-dione

C22H30O3 (342.21948299999997)


   

5-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)resorcinol

5-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   

5-((5Z,8Z,11Z)-heptadeca-5,8,11-trien-1-yl)resorcinol

5-((5Z,8Z,11Z)-heptadeca-5,8,11-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   

5-((8Z,11Z,14E)-heptadeca-8,11,14-trienyl) resorcinol

5-((8Z,11Z,14E)-heptadeca-8,11,14-trienyl) resorcinol

C23H34O2 (342.2558664)


   

Anacardic Acid

2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzoic acid

C22H30O3 (342.21948299999997)


   

4,7,10,13,16,19-Docosahexaenoic acid, methyl ester

cis-4,7,10,13,16,19-docosahexaenoic acid methyl ester

C23H34O2 (342.2558664)


   

bis(2-ethylhexyl) succinate

bis(2-ethylhexyl) succinate

C20H38O4 (342.2769948)


   

(D-Pro12)-α-MSH (11-13) (free acid)

(D-Pro12)-α-MSH (11-13) (free acid)

C16H30N4O4 (342.226694)


   

(S)-4-N-TRITYL-2-METHYL-PIPERAZINE

(S)-4-N-TRITYL-2-METHYL-PIPERAZINE

C24H26N2 (342.2095876)


   

4-(trans-4-pentylcyclohexyl)-3,4-difluorobiphenyl

4-(trans-4-pentylcyclohexyl)-3,4-difluorobiphenyl

C23H28F2 (342.2158952)


   

(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

C22H30O3 (342.21948299999997)


   

Triethyl(methyl)phosphonium dibutyl phosphate

Triethyl(methyl)phosphonium dibutyl phosphate

C15H36O4P2 (342.2088716)


   

methyl docosahexaenoate

methyl docosahexaenoate

C23H34O2 (342.2558664)


   

Retinyl Propionate

Retinyl Propionate

C23H34O2 (342.2558664)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

Sensorcaine

Bupivacaine hydrochloride

C18H31ClN2O2 (342.2073936)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

2-METHOXY-5-(3 7-DIMETHYLOCTYLOXY)BEN&

2-METHOXY-5-(3 7-DIMETHYLOCTYLOXY)BEN&

C21H30N2O2 (342.230716)


   

BIS(4-(VINYLOXY)BUTYL) ADIPATE

BIS(4-(VINYLOXY)BUTYL) ADIPATE

C18H30O6 (342.204228)


   

3,4-dihydroxy-4-[(3E,6E)-tetradeca-3,6-dienoyl]oxybutanoic acid

3,4-dihydroxy-4-[(3E,6E)-tetradeca-3,6-dienoyl]oxybutanoic acid

C18H30O6 (342.204228)


   

2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane

2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane

C18H39N4P (342.29121840000005)


   

cocamidopropyl βine

Lauramidopropyl betaine

C19H38N2O3 (342.28822779999996)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D013501 - Surface-Active Agents

   

1-Methyl-3-tetradecyl-1H-imidazolium nitrate

1-Methyl-3-tetradecyl-1H-imidazolium nitrate

C18H36N3O3 (342.27565260000006)


   

ethenyl acetate,4-ethyl-2-methylideneoctanoic acid,prop-2-enoic acid

ethenyl acetate,4-ethyl-2-methylideneoctanoic acid,prop-2-enoic acid

C18H30O6 (342.204228)


   

1-Trityl-(R)-3-methylpiperazine

1-Trityl-(R)-3-methylpiperazine

C24H26N2 (342.2095876)


   

9-Octadecenoic acid,12-hydroxy-, 2-hydroxyethyl ester, (9Z,12R)-

9-Octadecenoic acid,12-hydroxy-, 2-hydroxyethyl ester, (9Z,12R)-

C20H38O4 (342.2769948)


   

2-Mercaptoethyl oleate

2-Mercaptoethyl oleate

C20H38O2S (342.2592368)


   

3-(2-hydroxypropoxycarbonyl)-2-prop-2-enyl-2,3-dipropylhexanoic acid

3-(2-hydroxypropoxycarbonyl)-2-prop-2-enyl-2,3-dipropylhexanoic acid

C19H34O5 (342.24061140000003)


   

CIS CIS-1 3 5-TRIPROPYL-1 3 5-CYCLOHEXA&

CIS CIS-1 3 5-TRIPROPYL-1 3 5-CYCLOHEXA&

C18H30O6 (342.204228)


   

1,2:5,6-DI-O-CYCLOHEXYLIDENE-D-MANNITOL

1,2:5,6-DI-O-CYCLOHEXYLIDENE-D-MANNITOL

C18H30O6 (342.204228)


   

1-hexadecyl-3-methylimidazol-3-ium,chloride

1-hexadecyl-3-methylimidazol-3-ium,chloride

C20H39ClN2 (342.2801604)


   

4-Ethyl-2,3-difluoro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

4-Ethyl-2,3-difluoro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

C23H28F2 (342.2158952)


   

Trimegestone

Trimegestone

C22H30O3 (342.21948299999997)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C389 - Oral Contraceptive

   

Didecanoyl peroxide

Didecanoyl peroxide

C20H38O4 (342.2769948)


   

2-Dodecyl-3-hydroxy-1,4-naphthoquinone

2-Dodecyl-3-hydroxy-1,4-naphthoquinone

C22H30O3 (342.21948299999997)


   

butyl 2-methylprop-2-enoate,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate

butyl 2-methylprop-2-enoate,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate

C18H30O6 (342.204228)


   

diisooctyl succinate

diisooctyl succinate

C20H38O4 (342.2769948)


   
   
   

Cardenolide

Cardenolide

C23H34O2 (342.2558664)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

20-Carboxy-1,4-pregnadien-3-one

20-Carboxy-1,4-pregnadien-3-one

C22H30O3 (342.21948299999997)


   
   

{(3r,4r)-4-Methyl-3-[methyl(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)amino]piperidin-1-Yl}(Pyrrolidin-1-Yl)methanone

{(3r,4r)-4-Methyl-3-[methyl(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)amino]piperidin-1-Yl}(Pyrrolidin-1-Yl)methanone

C18H26N6O (342.2167986)


   

Myrsinoic acid A

Myrsinoic acid A

C22H30O3 (342.21948299999997)


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted by a geranyl group at position 3 and a prenyl group at position 5. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.

   

1,3-Benzenediol, 5-(8,11,14-heptadecatrienyl)-, (Z,Z,Z)-

1,3-Benzenediol, 5-(8,11,14-heptadecatrienyl)-, (Z,Z,Z)-

C23H34O2 (342.2558664)


   
   

L-Valine, N-(1-L-lysyl-L-prolyl)-

L-Valine, N-(1-L-lysyl-L-prolyl)-

C16H30N4O4 (342.226694)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D009074 - Melanocyte-Stimulating Hormones

   

1-(1-Adamantylcarbonyl)-4-(2-fluorophenyl)piperazine

1-(1-Adamantylcarbonyl)-4-(2-fluorophenyl)piperazine

C21H27FN2O (342.2107304)


   

Tributyl (E)-Aconitate

Tributyl (E)-Aconitate

C18H30O6 (342.204228)


   

Octanedioic acid, dihexyl ester

Octanedioic acid, dihexyl ester

C20H38O4 (342.2769948)


   

Carboxymethyl stearate

Carboxymethyl stearate

C20H38O4 (342.2769948)


   

Dibutyl dodecanedioate

Dibutyl dodecanedioate

C20H38O4 (342.2769948)


   

Trimethylsilyl heptadecanoate

Trimethylsilyl heptadecanoate

C20H42O2Si (342.2953912)


   

Prostaglandin F1alpha Alcohol

Prostaglandin F1alpha Alcohol

C20H38O4 (342.2769948)


   

(4Z,7Z,10Z,12E,14E)-15-{(2S,3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,12,14-pentaenoic acid

(4Z,7Z,10Z,12E,14E)-15-{(2S,3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,12,14-pentaenoic acid

C22H30O3 (342.21948299999997)


   

(13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

(13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

C22H30O3 (342.21948299999997)


An epoxy fatty acid consisting of (4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid having an epoxy group at the 13,14-position. An intermediate lipid in specialized proresolving mediators

   

2,3-Dinor-6,15-dioxo-13,14-dihydroprostaglandin F1alpha

5-[3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


   
   

2-hydroxyethyl (E)-12-hydroxyoctadec-9-enoate

Poly(oxy-1,2-ethanediyl),a-[(9Z,12R)-12-hydroxy-1-oxo-9-octadecen-1-yl]-w-hydroxy-

C20H38O4 (342.2769948)


   

[3-carboxy-2-[(E)-dodec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-5-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

C21H33F3 (342.25342140000004)


   

(Z)-5-((2R,3S,4S,6R)-4,6-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)tetrahydro-2H-pyran-3-yl)pent-3-enoic acid

(Z)-5-((2R,3S,4S,6R)-4,6-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)tetrahydro-2H-pyran-3-yl)pent-3-enoic acid

C18H30O6 (342.204228)


   

14-oxo-(4Z,7Z,10Z,12E,16Z,19Z)-Docosahexaenoate

14-oxo-(4Z,7Z,10Z,12E,16Z,19Z)-Docosahexaenoate

C22H30O3 (342.21948299999997)


   

5-[(1S,2S,3S,5R)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid

5-[(1S,2S,3S,5R)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid

C18H30O6 (342.204228)


   

[(1S)-3-carboxy-1-[(E)-dodec-2-enoyl]oxypropyl]-trimethylazanium

[(1S)-3-carboxy-1-[(E)-dodec-2-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotetradec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotetradec-4-enyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-2-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

(3-Carboxy-2-dodec-11-enoyloxypropyl)-trimethylazanium

(3-Carboxy-2-dodec-11-enoyloxypropyl)-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-9-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-4-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-7-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-8-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-3-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

[3-carboxy-2-[(E)-dodec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dodec-6-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

5-[2,4-dihydroxy-6-[(E)-3-hydroxyoct-1-enyl]cyclohexyl]pentanoic acid

5-[2,4-dihydroxy-6-[(E)-3-hydroxyoct-1-enyl]cyclohexyl]pentanoic acid

C19H34O5 (342.24061140000003)


   

(E)-5-[3,5-dihydroxy-2-(8-hydroxy-3-oxooctyl)cyclopentyl]pent-3-enoic acid

(E)-5-[3,5-dihydroxy-2-(8-hydroxy-3-oxooctyl)cyclopentyl]pent-3-enoic acid

C18H30O6 (342.204228)


   

Ferruginene C

Ferruginene C

C22H30O3 (342.21948299999997)


A natural product found in Rhododendron ferrugineum.

   

12-Hydroxy-13-(hydroxymethyl)-3,5,7-trimethyl-2,4-tetradecadienedioic acid

12-Hydroxy-13-(hydroxymethyl)-3,5,7-trimethyl-2,4-tetradecadienedioic acid

C18H30O6 (342.204228)


   

(4Z,7Z,10Z,13Z,15E,19Z)-17-Oxodocosahexaenoic acid

(4Z,7Z,10Z,13Z,15E,19Z)-17-Oxodocosahexaenoic acid

C22H30O3 (342.21948299999997)


An oxodocosahexaenoic acid that is (4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid in which the oxo group is located at position 17. An intermediate of specialised proresolving mediators.

   

(4Z,7Z,10Z,14E,16Z,19Z)-13-Oxodocosahexaenoic acid

(4Z,7Z,10Z,14E,16Z,19Z)-13-Oxodocosahexaenoic acid

C22H30O3 (342.21948299999997)


An oxodocosahexaenoic acid that is (4Z,7Z,10Z,14E,16Z,19Z)-docosahexaenoic acid in which the oxo group is located at position 13. An intermediate of specialised proresolving mediators.

   

6alpha-Methyl-11-oxoprogesterone

6alpha-Methyl-11-oxoprogesterone

C22H30O3 (342.21948299999997)


   
   

omega-(3-Oxo-17-beta-hydroxy-4-androsten-17-alpha-yl) propionic acid lactone

omega-(3-Oxo-17-beta-hydroxy-4-androsten-17-alpha-yl) propionic acid lactone

C22H30O3 (342.21948299999997)


   

14-oxo-DoHE

14-oxo-DoHE

C22H30O3 (342.21948299999997)


An oxo fatty acid that consists of (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid carrying a single oxo substituent at position 14.

   

(1S,3S,4R,7S,8S,11S,12S,13S,15R,20R)-7-Formamido-20-isocyanoisocycloamphilectane

(1S,3S,4R,7S,8S,11S,12S,13S,15R,20R)-7-Formamido-20-isocyanoisocycloamphilectane

C22H34N2O (342.2670994)


A tetracyclic diterpenoid that is hexadecahydropyrene substituted by isocyano group at position 8, methyl groups at positions 1, 4, 7 and 8 and a formamido group at position 1. Isolated from the tropical marine sponge Cymbastela hooperi, it exhibits antiplasmodial activity.

   

(4Z,7Z,10Z,13Z)-15-{(3R)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoic acid

(4Z,7Z,10Z,13Z)-15-{(3R)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoic acid

C22H30O3 (342.21948299999997)


   
   
   
   

2-(2-Pentadecyl-1,3-dioxolan-2-yl)acetic acid

2-(2-Pentadecyl-1,3-dioxolan-2-yl)acetic acid

C20H38O4 (342.2769948)


   

Levobupivacaine hydrochloride hydrate

Levobupivacaine hydrochloride hydrate

C18H31ClN2O2 (342.2073936)


   

(9S,16S)-dihydroperoxy-(10E,12Z,14E)-octadecatrienoic acid

(9S,16S)-dihydroperoxy-(10E,12Z,14E)-octadecatrienoic acid

C18H30O6 (342.204228)


   

L-Leucine, N-(N-acetyl-L-leucyl)-, butyl ester

L-Leucine, N-(N-acetyl-L-leucyl)-, butyl ester

C18H34N2O4 (342.25184440000004)


   

(4S,7R)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7R)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C19H26N4O2 (342.2055656)


   

(4S,7S)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7S)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C19H26N4O2 (342.2055656)


   

(5S,8S)-8-(phenylmethyl)-5-propan-2-yl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S,8S)-8-(phenylmethyl)-5-propan-2-yl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C19H26N4O2 (342.2055656)


   

(4R,7R)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C19H26N4O2 (342.2055656)


   

(4R,7S)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7S)-4-(phenylmethyl)-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C19H26N4O2 (342.2055656)


   

(5R,8R)-8-(phenylmethyl)-5-propan-2-yl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5R,8R)-8-(phenylmethyl)-5-propan-2-yl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C19H26N4O2 (342.2055656)


   
   
   
   
   

Dextrobupivacaine hydrochloride hydrate

Dextrobupivacaine hydrochloride hydrate

C18H31ClN2O2 (342.2073936)


   

6beta,17-Dihydroxy-3,5-cyclo-5alpha,17alpha-pregn-20-ene-21-carboxylic acid, gamma-lactone

6beta,17-Dihydroxy-3,5-cyclo-5alpha,17alpha-pregn-20-ene-21-carboxylic acid, gamma-lactone

C22H30O3 (342.21948299999997)


   

(4Z,7Z,10Z,13Z)-15-{(3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoic acid

(4Z,7Z,10Z,13Z)-15-{(3S)-3-[(2Z)-pent-2-en-1-yl]oxiran-2-ylidene}pentadeca-4,7,10,13-tetraenoic acid

C22H30O3 (342.21948299999997)


   

2,3-dihydroxypropyl (E)-15-methylhexadec-9-enoate

2,3-dihydroxypropyl (E)-15-methylhexadec-9-enoate

C20H38O4 (342.2769948)


   

(17R)-17-ethynyl-17-hydroxy-2-(hydroxymethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

(17R)-17-ethynyl-17-hydroxy-2-(hydroxymethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

C22H30O3 (342.21948299999997)


   

(2R,8R,9S,10R,13S,14S)-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-spiro[cyclopenta[a]phenanthrene-17,2-furan]-3,5(2H,4H)-dione

(2R,8R,9S,10R,13S,14S)-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-spiro[cyclopenta[a]phenanthrene-17,2-furan]-3,5(2H,4H)-dione

C22H30O3 (342.21948299999997)


   

[3-carboxy-1-[(Z)-dodec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-1-[(Z)-dodec-5-enoyl]oxypropyl]-trimethylazanium

C19H36NO4+ (342.26441960000005)


   

2,3-dihydroxypropyl (Z)-heptadec-9-enoate

2,3-dihydroxypropyl (Z)-heptadec-9-enoate

C20H38O4 (342.2769948)


   

9-Acetyloxyoctadecanoic acid

9-Acetyloxyoctadecanoic acid

C20H38O4 (342.2769948)


   

7-Hydroxy-pregna-1,4-dien-3-one-20-carbaldehyde

7-Hydroxy-pregna-1,4-dien-3-one-20-carbaldehyde

C22H30O3 (342.21948299999997)


   
   

[(2~{S})-2,3-bis(oxidanyl)propyl] heptadec-9-enoate

[(2~{S})-2,3-bis(oxidanyl)propyl] heptadec-9-enoate

C20H38O4 (342.2769948)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] acetate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] acetate

C20H38O4 (342.2769948)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] butanoate

C20H38O4 (342.2769948)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] propanoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] propanoate

C20H38O4 (342.2769948)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(4AS,5S,8AS)-(-)-5alpha-(3-Hydroxypropyl)-8A-methoxymethoxymethyl-5beta-methyl-3,4,4A,5,6,7,8,8A-octahydronaphthalen-1(2H)-one1-ethylene acetal

(4AS,5S,8AS)-(-)-5alpha-(3-Hydroxypropyl)-8A-methoxymethoxymethyl-5beta-methyl-3,4,4A,5,6,7,8,8A-octahydronaphthalen-1(2H)-one1-ethylene acetal

C19H34O5 (342.24061140000003)


   

14-Methylhexadecanoic acid trimethylsilyl ester

14-Methylhexadecanoic acid trimethylsilyl ester

C20H42O2Si (342.2953912)


   

2-Hexyl-3,4-diacetoxy-1,6-dioxaspiro[4.5]decane

2-Hexyl-3,4-diacetoxy-1,6-dioxaspiro[4.5]decane

C18H30O6 (342.204228)


   

Octane-3,6-dimethyl-1,8-bis-(2-oxytetrahydro-2H-pyranyl)

Octane-3,6-dimethyl-1,8-bis-(2-oxytetrahydro-2H-pyranyl)

C20H38O4 (342.2769948)


   

(10,13-Dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) propanoate

(10,13-Dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) propanoate

C22H30O3 (342.21948299999997)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

C19H34O5 (342.24061140000003)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-tridec-9-enoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-tridec-9-enoate

C19H34O5 (342.24061140000003)


   

2-[(3-Hexoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Hexoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C14H33NO6P+ (342.2045388)


   

ethyl (2R,3R)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate

ethyl (2R,3R)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate

C17H30N2O5 (342.215461)


   

2,3-dinor-6-oxoprostaglandin F1alpha

2,3-dinor-6-oxoprostaglandin F1alpha

C18H30O6 (342.204228)


A prostanoid that is prostaglandin F1alpha lacking two methylenes in the carboxyalkyl chain and bearing an oxo group at the 6-position.

   

13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid

13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid

C19H34O5 (342.24061140000003)


   

(2

A,17xi)-17-hydroxy-2-(hydroxymethyl)pregn-4-en-20-yn-3-one

C22H30O3 (342.21948299999997)


   

2,3-Dinor-6-keto-prostaglandin F1 a

2,3-Dinor-6-keto-prostaglandin F1 a

C18H30O6 (342.204228)


   

(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid

(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid

C18H30O6 (342.204228)


   

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

(4Z,8E,10Z,13Z,16Z,19Z)-7-oxodocosahexaenoic acid

(4Z,8E,10Z,13Z,16Z,19Z)-7-oxodocosahexaenoic acid

C22H30O3 (342.21948299999997)


A oxodocosahexaenoic acid that consists of (4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoic acid carrying an oxo substituent at position 7. An intermediate of specialised proresolving mediators.

   

2-Hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid

2-Hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid

C22H30O3 (342.21948299999997)


   

6Z,8E-tricosdien-4,19-diynoic acid

6Z,8E-tricosdien-4,19-diynoic acid

C23H34O2 (342.2558664)


   

(16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid

(16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid

C22H30O3 (342.21948299999997)


An epoxy fatty acid consisting of (4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid having an epoxy group located at the 16,17-position. An intermediate lipid in specialized proresolving mediators.

   

DG(16:1)

DG(4:0_12:1)

C19H34O5 (342.24061140000003)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Dinorketo-prostaglandin F1 alpha

Dinorketo-prostaglandin F1 alpha

C18H30O6 (342.204228)


   
   
   

Tricosahexaenoic acid

Tricosahexaenoic acid

C23H34O2 (342.2558664)


   
   

FAHFA 10:0/3O-10:0

FAHFA 10:0/3O-10:0

C20H38O4 (342.2769948)


   

FAHFA 10:0/O-10:0

FAHFA 10:0/O-10:0

C20H38O4 (342.2769948)


   

FAHFA 11:0/3O-9:0

FAHFA 11:0/3O-9:0

C20H38O4 (342.2769948)


   
   

FAHFA 12:0/3O-8:0

FAHFA 12:0/3O-8:0

C20H38O4 (342.2769948)


   
   

FAHFA 14:0/3O-6:0

FAHFA 14:0/3O-6:0

C20H38O4 (342.2769948)


   

FAHFA 4:0/3O-16:0

FAHFA 4:0/3O-16:0

C20H38O4 (342.2769948)


   

FAHFA 5:0/15O-15:0

FAHFA 5:0/15O-15:0

C20H38O4 (342.2769948)


   

FAHFA 6:0/2O-14:0

FAHFA 6:0/2O-14:0

C20H38O4 (342.2769948)


   

FAHFA 7:0/3O-13:0

FAHFA 7:0/3O-13:0

C20H38O4 (342.2769948)


   

FAHFA 8:0/3O-12:0

FAHFA 8:0/3O-12:0

C20H38O4 (342.2769948)


   
   

FAHFA 9:0/3O-11:0

FAHFA 9:0/3O-11:0

C20H38O4 (342.2769948)


   
   
   
   
   
   
   
   
   

2-(8-hydroxy-4,8-dimethylnona-3,6-dien-1-yl)-2,7-dimethylchromen-5-ol

2-(8-hydroxy-4,8-dimethylnona-3,6-dien-1-yl)-2,7-dimethylchromen-5-ol

C22H30O3 (342.21948299999997)


   

3-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-4-hydroxybenzoic acid

3-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-4-hydroxybenzoic acid

C22H30O3 (342.21948299999997)


   

(3as,3br,9as,9bs,11as)-3a,6,6,9b,11a-pentamethyl-2h,3h,3bh,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-1,4,7-trione

(3as,3br,9as,9bs,11as)-3a,6,6,9b,11a-pentamethyl-2h,3h,3bh,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-1,4,7-trione

C22H30O3 (342.21948299999997)


   

5-(heptadeca-8,11,16-trien-1-yl)benzene-1,3-diol

5-(heptadeca-8,11,16-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   
   

(3z,7e,11e,13r)-13-methoxy-3,7,11-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11,14,17-hexaene-15,17-diol

(3z,7e,11e,13r)-13-methoxy-3,7,11-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11,14,17-hexaene-15,17-diol

C22H30O3 (342.21948299999997)


   

methyl 3-methoxy-4,7-dimethyl-9-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalene-1-carboxylate

methyl 3-methoxy-4,7-dimethyl-9-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalene-1-carboxylate

C22H30O3 (342.21948299999997)


   

3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl benzoate

3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl benzoate

C22H30O3 (342.21948299999997)


   

methyl 7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

methyl 7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate

C18H30O6 (342.204228)


   

4-hydroxy-3-[(2z,6z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzoic acid

4-hydroxy-3-[(2z,6z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzoic acid

C22H30O3 (342.21948299999997)


   

13-methoxy-3,7,11-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11,14,17-hexaene-15,17-diol

13-methoxy-3,7,11-trimethylbicyclo[12.2.2]octadeca-1(16),3,7,11,14,17-hexaene-15,17-diol

C22H30O3 (342.21948299999997)


   

5-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]benzene-1,3-diol

5-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]benzene-1,3-diol

C23H34O2 (342.2558664)


   

(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl benzoate

(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl benzoate

C22H30O3 (342.21948299999997)


   

(2e,4z,6z)-7-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-8h-oxocin-3-ol

(2e,4z,6z)-7-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-8h-oxocin-3-ol

C23H34O2 (342.2558664)


   

3-[(3e,6e,8r)-11-(furan-3-yl)-8-methoxy-4,8-dimethylundeca-3,6-dien-1-yl]furan

3-[(3e,6e,8r)-11-(furan-3-yl)-8-methoxy-4,8-dimethylundeca-3,6-dien-1-yl]furan

C22H30O3 (342.21948299999997)


   

4-methoxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol

4-methoxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol

C23H34O2 (342.2558664)


   

methyl (4r,6as,7s,9s)-3-methoxy-4,7-dimethyl-9-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalene-1-carboxylate

methyl (4r,6as,7s,9s)-3-methoxy-4,7-dimethyl-9-(2-methylprop-1-en-1-yl)-5,6,6a,7,8,9-hexahydro-4h-phenalene-1-carboxylate

C22H30O3 (342.21948299999997)


   

3-[11-(furan-3-yl)-8-methoxy-4,8-dimethylundeca-3,6-dien-1-yl]furan

3-[11-(furan-3-yl)-8-methoxy-4,8-dimethylundeca-3,6-dien-1-yl]furan

C22H30O3 (342.21948299999997)


   

2,5-dihydroxy-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzaldehyde

2,5-dihydroxy-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzaldehyde

C22H30O3 (342.21948299999997)


   

(1r,2r,4as,5s,8r,8ar)-1,5-diisocyano-2,5-dimethyl-8-(6-methylhept-5-en-2-yl)-octahydronaphthalen-2-ol

(1r,2r,4as,5s,8r,8ar)-1,5-diisocyano-2,5-dimethyl-8-(6-methylhept-5-en-2-yl)-octahydronaphthalen-2-ol

C22H34N2O (342.2670994)


   

(2e)-3-[(1s,3r,4r,7r,8r,11s)-3-[(2z)-but-2-en-2-yl]-4,6,8,10,11-pentamethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid

(2e)-3-[(1s,3r,4r,7r,8r,11s)-3-[(2z)-but-2-en-2-yl]-4,6,8,10,11-pentamethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid

C22H30O3 (342.21948299999997)


   

4-hydroxy-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzoic acid

4-hydroxy-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzoic acid

C22H30O3 (342.21948299999997)


   

3-[(4e,6s,8e)-11-(furan-3-yl)-6-methoxy-4,8-dimethylundeca-4,8-dien-1-yl]furan

3-[(4e,6s,8e)-11-(furan-3-yl)-6-methoxy-4,8-dimethylundeca-4,8-dien-1-yl]furan

C22H30O3 (342.21948299999997)


   

(2e,4s)-4-[(2s,3s,4r,5s,6s,8r,9s,10r)-4,10-dihydroxy-3,5,8,9-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]pent-2-enoic acid

(2e,4s)-4-[(2s,3s,4r,5s,6s,8r,9s,10r)-4,10-dihydroxy-3,5,8,9-tetramethyl-1,7-dioxaspiro[5.5]undecan-2-yl]pent-2-enoic acid

C18H30O6 (342.204228)


   

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11-trimethyldodeca-2,6,10-trien-5-one

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11-trimethyldodeca-2,6,10-trien-5-one

C22H30O3 (342.21948299999997)


   

(1r,2s,5r,8s,9r)-9-hydroxy-4,4,8-trimethyltricyclo[6.3.1.0¹,⁵]dodecan-2-yl benzoate

(1r,2s,5r,8s,9r)-9-hydroxy-4,4,8-trimethyltricyclo[6.3.1.0¹,⁵]dodecan-2-yl benzoate

C22H30O3 (342.21948299999997)